Bortezomib/Daratumumab/Melphalan/Prednisone Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bortezomib, daratumumab, melphalan and prednisone that can be used for the treatment of plasma cell (multiple) myeloma.

**Synonyms:** - Bortezomib-Daratumumab-Melphalan-Prednisone - Bortezomib-Daratumumab-Melphalan-Prednisone Regimen - Bortezomib/Daratumumab/Melphalan/Prednisone - Bortezomib/Melphalan/Prednisone Plus Daratumumab - Bortezomib/Melphalan/Prednisone/Daratumumab - Dara-VMP - Dara-VMP - Darzalex Plus VMP - Darzalex-VMP Regimen - VMP Regimen Plus Daratumumab - VMP-Darzalex - Velcade/Melphalan/Prednisone/Darzalex